Genomic Health does not give treatment for cancer or advise patients on their treatment plans. Anyone in doubt about their own health or cancer should seek medical advice from a qualified healthcare professional. By providing answers to key questions about the aggressiveness of and appropriate treatment for early-stage cancer, our practice-changing tests help physicians and patients select the right treatment at the right time in each individual case. In this way, Oncotype DX testing helps patients and their physicians to optimize their cancer care and outcomes, enabling many patients to avoid unnecessary procedures and therapies, and saving the healthcare system billions of dollars in unnecessary costs. With over 1 million patients tested in more than 90 countries, our Oncotype DX tests have helped define a standard of care in precision medicine by making genomics a critical part of cancer diagnosis and treatment.
Drugs make headway against lung, breast, prostate cancers
Researchers confirm links between aggressive prostate cancer and hereditary breast cancer
Many men wonder if they should get screened for prostate cancer. Each man must decide for himself. The answer is different for each man. If you are thinking about being screened, learn about the possible benefits and harms of screening, diagnosis, and treatment, and talk to your doctor about your personal risk factors. Cancer screening means looking for cancer before it causes symptoms. The goal of screening for prostate cancer is to find cancer early that may spread if not treated. There is no standard test to screen for prostate cancer.
Prostate cancer occurs in the prostate gland, which is located just below a male's bladder and surrounds the top portion of the tube that drains urine from the bladder urethra. This illustration shows a normal prostate gland and a prostate with a tumor. Prostate cancer is cancer that occurs in the prostate — a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm.
Aside from non-melanoma skin cancer, prostate cancer is the most common cancer among men in the United States. It is also one of the leading causes of cancer death among men of all races and Hispanic origin populations. The Data Visualizations tool makes it easy for anyone to explore and use the latest official federal government cancer data from United States Cancer Statistics. Skip directly to site content Skip directly to page options Skip directly to A-Z link. Prostate Cancer.